Interestingly, patients with dyslipidemia (high bad cholesterol and low good cholesterol level) had worse prognostic factors of breast cancer (i.e., negative hormone receptor status, positive HER2 expression, higher nuclear grade). This evidence concerns the gene ERBB2 and breast cancer.